hHLA-A2.1

Nomenclature

C57BL/6Smoc-H2-D1em1hHLA-A2*01Smoc

Cat. NO.

NM-KI-233927

Strain State

Repository Live

Export PDF

Model Description

The endogenous mouse H2-D1 gene was replaced by human HLA-A2*01 gene .

Validation Data

image.png

Fig.1 Detection of mH-2D and HLA-A2 expression on overall Leukocytes in hHLA-A2.01 dKI mice (female, 6-8wks).

image.png

Fig.2 Analysis of leukocytes cell subpopulation in HO hHLA-A2.01 and WT C57BL/6 mice (female, 6-8wks, n=3).

image.pngFig.3 Analysis of leukocytes cell subpopulation in Spleen (female, 6-8wks).

image.pngFig.4 Analysis of leukocytes cell subpopulation in Blood (female, 6-8wks).

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more